Puma Biotechnology (PBYI) Gross Margin (QoQ) (2017 - 2026)

Puma Biotechnology (PBYI) Gross Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Puma Biotechnology 451.24 Mn 357.33 Mn 44.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 118.00
Mar 31, 2026 739.00
Dec 31, 2025 -830.00
Sep 30, 2025 111.00
Jun 30, 2025 -51.00
Mar 31, 2025 62.00
Dec 31, 2024 1,256.00
Sep 30, 2024 -1,349.00
Jun 30, 2024 188.00
Mar 31, 2024 919.00
Dec 31, 2023 -1,003.00
Sep 30, 2023 -194.00
Jun 30, 2023 332.00
Mar 31, 2023 -584.00
Dec 31, 2022 267.00
Sep 30, 2022 318.00
Jun 30, 2022 -135.00
Mar 31, 2022 -222.00
Dec 31, 2021 74.00
Sep 30, 2021 19.00